Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/16/2014CA2530623C Assay for detecting atrial and brain natriuretic peptide prohormones
09/16/2014CA2526240C 7a5/prognostin and use thereof for the diagnostic and therapy of tumors
09/16/2014CA2512729C Identification and engineering of antibodies with variant fc regions and methods of using same
09/16/2014CA2504532C Botulinum neurotoxin b receptors and use thereof
09/16/2014CA2492556C Hsp70 from arthrobacter
09/16/2014CA2484420C Antibodies specific for human cd22 and their therapeutic and diagnostic uses
09/12/2014WO2014138738A1 Methods of treating acute kidney injury
09/12/2014WO2014138449A1 Anti-c-met tandem fc bispecific antibodies
09/12/2014WO2014138314A1 Oncolytic virus
09/12/2014WO2014138306A1 Engager cells for immunotherapy
09/12/2014WO2014138183A1 Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells
09/12/2014WO2014137961A1 Anti-tnf-anti-il-17 bispecific antibodies
09/12/2014WO2014137674A1 Human antibodies to serum resistance-associated protein from trypanosoma brucei rhodesiense
09/12/2014WO2014137355A1 Anti-cxcl13 antibodies and associated epitope sequences
09/12/2014WO2014137161A1 Improved preparation method for high-yield production of physiologically active polypeptide conjugate
09/12/2014WO2014136910A1 ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY
09/12/2014WO2014136814A1 Novel peptide having 5 linked ctl epitopes
09/12/2014WO2014136453A1 C12orf48 PEPTIDES AND VACCINES CONTAINING THE SAME
09/12/2014WO2014136443A1 ANTI-Aβ42 MONOCLONAL ANTIBODY
09/12/2014WO2014135730A1 Haptenes and conjugates derived from pyocyanin, antibodies thereof, and immunochemical method for detecting infections caused by pseudomonas aeruginosa
09/12/2014WO2014135611A1 Combination therapy for neoplasia treatment
09/12/2014WO2014135528A1 Fusion proteins and immunoconjugates and uses thereof
09/12/2014WO2014135420A1 Protein purification by means of aqueous two-phase centrifugal extraction
09/11/2014US20140256916 Immuno imaging agent for use with antibody-drug conjugate therapy
09/11/2014US20140256915 Velocity Factor
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140256648 Hjurp peptides and vaccines including the same
09/11/2014US20140256583 Detection of human endogenous retrovirus expression in cancer and normal cells
09/11/2014US20140256579 Protein Arrays
09/11/2014US20140256041 Methods of blocking cancer stem cell growth
09/11/2014US20140255996 Method for Secretory Production of Protein
09/11/2014US20140255995 High affinity antibodies to human il-6 receptor
09/11/2014US20140255994 Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
09/11/2014US20140255993 Mammalian cell culture
09/11/2014US20140255976 Capture, purification, and release of biological substances using a surface coating
09/11/2014US20140255951 Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
09/11/2014US20140255941 Receptor gene for peptide cancer antigen-specific t cell
09/11/2014US20140255437 Topk peptides and vaccines including the same
09/11/2014US20140255429 Methods of Treating Autoimmune Diseases with DLL4 Antagonists
09/11/2014US20140255425 Multi-CBV Vaccine for Preventing or Treating Type I Diabetes
09/11/2014US20140255424 Biomarkers of aging for detection and treatment of disorders
09/11/2014US20140255423 Isolation and purification of antibodies using protein a affinity chromatography
09/11/2014US20140255422 Antibodies that bind to il-23
09/11/2014US20140255421 Methods and Compositions for Treating Polyps
09/11/2014US20140255417 Modulation of macrophage activation
09/11/2014US20140255415 LINGO Binding Molecules and Pharmaceutical Use Thereof
09/11/2014US20140255414 Diagnostic antibody assay
09/11/2014US20140255413 Combination therapy for neoplasia treatment
09/11/2014US20140255412 Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell Lines
09/11/2014US20140255411 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
09/11/2014US20140255410 Specific binding proteins and uses thereof
09/11/2014US20140255408 Bispecific EGFR/C-Met Antibodies
09/11/2014US20140255407 Bispecific Molecules That Are Immunoreactive with Immune Effector Cells of a Companion Animal That Express an Activating Receptor and Cells That Express B7-H3 and Uses Thereof
09/11/2014US20140255406 Anti-tnf-anti-il-17 bispecific antibodies
09/11/2014US20140255405 Removal of Monomeric Targets
09/11/2014US20140255404 Pulmonary hypertension
09/11/2014US20140255400 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use
09/11/2014US20140255399 Separation method for fucosylated antibodies
09/11/2014US20140255398 Antigen-binding molecule inducing immune response to target antigen
09/11/2014US20140255397 Methods and compositions for modulation of blood-neural barrier
09/11/2014US20140255396 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/11/2014US20140255395 Complement inhibition for improved nerve regeneration
09/11/2014US20140255393 Compositions and methods for autoimmune disease
09/11/2014US20140255391 Methods for the treatment of il-1beta related diseases
09/11/2014US20140255390 Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody
09/11/2014US20140255389 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
09/11/2014US20140255388 Toll like receptor 3 antagonists, methods and uses
09/11/2014US20140255343 Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine
09/11/2014US20140255305 Immuno imaging agent for use with antibody-drug conjugate therapy
09/11/2014US20140255304 Tdp-43 specific binding molecules
09/11/2014US20140255303 Anti-vcam-1 nanobodies
09/11/2014US20140255302 ANTIBODIES AGAINST TL1a AND USES THEREOF
09/10/2014EP2774984A1 Monoclonal antibody against human non-small-cell lung carcinoma and use thereof
09/10/2014EP2774620A1 Method for modulating weight loss
09/10/2014EP2773773A1 T-cell receptor clonotypes shared among ankylosing spondylitis patients
09/10/2014EP2773766A1 In vivo adcc model
09/10/2014EP2773671A1 Stable heterodimeric antibody design with mutations in the fc domain
09/10/2014EP2773670A2 Antibody and methods for selective inhibition of t-cell responses
09/10/2014EP2773669A1 Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs
09/10/2014EP2773668A1 Pulmonary hypertension
09/10/2014EP2773667A1 Anti-gpr49 antibodies
09/10/2014EP2773666A1 Antigen binding protein and its use as addressing product for the treatment of cancer
09/10/2014EP2773665A1 Antibodies and methods of treating cancer
09/10/2014EP2773664A1 Anti-gpr49 antibodies
09/10/2014EP2773663A1 Antigen binding protein and its use as addressing product for the treatment cancer
09/10/2014EP2773662A1 Antibody formulations
09/10/2014EP2773661A1 Method for preparing antibodies having improved properties
09/10/2014EP2773660A2 Chimeric human-camel antigens and their use
09/10/2014EP2773651A1 Isolated b7-h4 specific compositions and methods of use thereof
09/10/2014EP2773439A1 Chromatography process for resolving heterogeneous antibody aggregates
09/10/2014EP2773427A2 Medical use
09/10/2014EP2773374A2 Methods for reducing the frequency and severity of acute exacerbations of asthma
09/10/2014EP2773373A1 Methods of blocking cancer stem cell growth
09/10/2014EP2773221A1 Simultaneous purification of cell components
09/09/2014US8829176 Beta-actin and RPS21 promoters and uses thereof
09/09/2014US8829175 Nucleic acids encoding polyvalent protein complexes
09/09/2014US8829165 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
09/09/2014US8829164 Anti-ron antibodies
09/09/2014US8829163 Liquid formulations for long-acting erythropoietin conjugate
09/09/2014US8829162 In vitro method for diagnosing prostate cancer
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 1494